Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-20

Clinical Trial Update: Efficacy of Biofeedback in the Treatment of Tic Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating biofeedback for tic disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Tic Disorders | Phase 4 | Status: WITHDRAWN